Minophagen extends marketing rights to bexarotene for T-Cell Lymphoma - 04-Apr-2012
Minophagen Pharma has acquired further rights to market the synthetic retinoid bexarotene from Eisai. Minophagen has added to its rights to market in Japan the territories of Asia, Oceana, the Middle East and Eastern Europe.The drug is marketed in 20 countries for refractory/recurrent T-Cell Lymphoma and in the USA by Eisai as Targretin.
Related News
Belinostat (TopoTarget/Spectrum) success in BELIEF study for PTCL
CHMP refuses recommendation of Istodax( Celgene) for T-cell Lymphoma
Minophagen extends marketing rights to bexarotene for T-Cell Lymphoma
CHMP rejects Folotyn (AllosTherapeutics and Mundipharma) for T-Cell Lymphoma
Mechlorethamine hydrochloride gel is filed at FDA for Mycosis Fungoides
Phase III study of Tomtovok (Boehringer) meets endpoint for NSCLC
IDMC halts Phase III study of Vargatef (Boehringer) in NSCLC
FDA approves Xofigo (Bayer HealthCare) for Prostate Cancer
Related Oncology Information
Oncology Clinical Guidelines
Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
NICEProstate cancer: diagnosis and treatment
NICEOncology Clinical Trials
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinicaltrials.gov 08 April 2013Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (CONKO-007)
Clinicaltrials.gov 04 April 2013Oncology Medical Journal Abstracts
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
Lung Cancer 24 April 2013Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Lung Cancer 22 April 2013Oncology Medical Apps
CCO Oncology inPractice
Free
Cancer Signs and Symptoms
Free
Related Oncology Drugs
- TAXOTERE 80MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TAXOL
- TYVERB
- FEMARA
- FARESTON
- FLUDARA ORAL 10 MG FILM-COATED TABLET
- VESANOID 10MG SOFT CAPSULES
- TEPADINA 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- TAXOTERE 160MG/8ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ROFERON-A 18MIU/0.6ML CARTRIDGE
- UTOVLAN
- ZALTRAP 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- ONKOTRONE INJECTION
- MAXTREX TABLETS 2.5 MG
- NAVELBINE 10 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION
- SUTENT 12.5MG, 25MG, 37.5MG AND 50MG HARD CAPSULES
- XAGRID 0.5MG HARD CAPSULE
- CYPROSTAT 100MG
- GEMCITABINE 200 MG POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 1 G POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 2 G POWDER FOR SOLUTION FOR INFUSION
- HERCEPTIN 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- PARAPLATIN
- HYCAMTIN 1MG AND 4MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- FASLODEX 250 MG SOLUTION FOR INJECTION
- TESTOSTERONE ENANTATE AMPOULES
- YONDELIS SOLUTION FOR INFUSION.
- PHARMORUBICIN
- VELCADE 3.5 MG POWDER FOR SOLUTION FOR INJECTION.
- CARDIOXANE 500MG POWDER FOR SOLUTION FOR INFUSION
- CAMPTO 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- NOVGOS
- MITOMYCIN C
- PROSTAP SR DCS
- PROVERA TABLETS 100 MG
- MAXTREX TABLETS 10 MG
- XALUPRINE
- UFTORAL HARD CAPSULES
- LEUKERAN TABLETS 2 MG
- VOTRIENT 200 MG FILM-COATED TABLETS
- ERBITUX 5MG/ML SOLUTION FOR INFUSION
- NEXAVAR 200MG FILM-COATED TABLETS
- KYTRIL TABLETS 1MG AND 2MG
- ESTRACYT CAPSULES
- MYOCET
- VOTRIENT 200 MG FILM-COATED TABLETS
- SOLTAMOX
- AVASTIN 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- GLIADEL 7.7MG IMPLANT
- FIRMAGON 80MG INJECTION
- CARBOPLATIN 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CYCLOPHOSPHAMIDE 50 TABLETS
- LEVOFOLINIC ACID 50 MG/ML SOLUTION FOR INJECTION OR INFUSION
- ELOXATIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ATRIANCE 5 MG/ML SOLUTION FOR INFUSION
- ETOPOPHOS 100MG POWDER FOR SOLUTION FOR INJECTION
- PERJETA 420 MG CONCENTRATE FOR SOLUTION FOR INFUSION
- GRANISETRON
- TAXOTERE 20MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TOMUDEX
- CYPROSTAT 50MG
- HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION
- TAXCEUS 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TASIGNA 200 MG HARD CAPSULES
- TOPOTECAN 4 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- DOXORUBICIN 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CASODEX 150 MG FILM-COATED TABLETS.
- TARCEVA 25MG, 100MG AND 150MG FILM-COATED TABLETS
- CAELYX 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CASODEX 50 MG FILM-COATED TABLETS
- PROLEUKIN
- JEVTANA
- CYTARABINE INJECTION SOLUTION 20MG/ML AND 100MG/ML
- HYCAMTIN 0.25MG AND 1 MG HARD CAPSULE
- EVOLTRA 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ERWINASE
- HYDREA 500 MG HARD CAPSULES
- FIRMAGON 120MG INJECTION
- GLIVEC
- BICALUTAMIDE 50MG FILM-COATED TABLETS
- PROSTAP 3 LEUPRORELIN ACETATE DEPOT INJECTION 11.25MG
- XELODA 150MG AND 500MG FILM-COATED TABLETS
- AROMASIN
- ZOLADEX
- PROSTAP SR
- ROFERON-A PRE-FILLED SYRINGE
- PROSTAP 3 DCS
- NASTROSA 1MG FILM-COATED TABLETS
- BICALUTAMIDE 150MG FILM-COATED TABLETS
- REVLIMID
- SPRYCEL 20MG, 50MG, 80MG, 100MG AND 140MG FILM COATED TABLETS
- LEUSTAT INJECTION
- PHOTOFRIN
- ZAVEDOS
- FLUOROURACIL 25 MG/ML INJECTION
- IRESSA 250MG FILM-COATED TABLETS
- VINCRISTINE SULPHATE 1 MG/ML INJECTION
- MITOXANTRONE (MITOZANTRONE) 2 MG/ML STERILE CONCENTRATE
- VINBLASTINE SULPHATE 1 MG/ML INJECTION
- TAMOFEN (CARCINOMA)
- VEPESID SOFT CAPSULES 50 MG AND 100 MG
- MEGACE 160 MG TABLETS
- MABTHERA 100MG AND 500MG CONCENTRATE FOR SOLUTION FOR INFUSION
- ARIMIDEX 1MG FILM-COATED TABLET
- NIPENT 10 MG POWDER FOR SOLUTION FOR INJECTION, POWDER FOR SOLUTION FOR INFUSION
- ONCOTICE
- DACARBAZINE 100MG, 200MG, 500MG, 1000MG
- DAUNOXOME INJECTION (LIPOSOMAL DAUNORUBICIN)
- EFUDIX CREAM
- TEMODAL CAPSULES
- ISOVORIN
- GEMZAR 200MG POWDER FOR SOLUTION FOR INFUSION, GEMZAR 1000MG POWDER FOR SOLUTION FOR INFUSION
- PROCARBAZINE CAPSULES 50MG
Advert for Healthcare Professionals only